| Literature DB >> 21572910 |
Rita De Gasperi1, Miguel A Gama Sosa, Zuzanna Naumowicz, Patrick R Hof, Lucia Notterpek, Kenneth L Davis, Joseph D Buxbaum, Gregory A Elder.
Abstract
Myelin abnormalities exist in schizophrenia leading to the hypothesis that oligodendrocyte dysfunction plays a role in the pathophysiology of the disease. The expression of the mRNA for the peripheral myelin protein-22 (PMP-22) is decreased in schizophrenia and recent genetic evidence suggests a link between PMP-22 and schizophrenia. While PMP-22 mRNA is found in both rodent and human brain it has been generally thought that no protein expression occurs. Here we show that PMP-22 protein is present in myelin isolated from adult mouse and human brain. These results suggest that PMP-22 protein likely plays a role in the maintenance and function of central nervous system (CNS) myelin and provide an explanation for why altered PMP-22 expression may be pathophysiologically relevant in a CNS disorder such as schizophrenia.Entities:
Year: 2010 PMID: 21572910 PMCID: PMC3093192 DOI: 10.2478/v10134-010-0038-3
Source DB: PubMed Journal: Transl Neurosci ISSN: 2081-6936 Impact factor: 1.757